Abstract Library

#4439 Survival of 10,418 lung neuroendocrine tumours after surgical resection: Who needs follow-up and for how long?

Introduction: Surgical resection is the primary treatment for lung neuroendocrine tumours (NETs). The optimal follow-up period is debated in these patients.

Conference:

Presenting Author: El Asmar M

Authors: El Asmar M, Mortagy M, Chandrakumaran K, Ramage J,

Keywords: Lung, Neuroendocrine tumour, survival, surgery, follow-up period,

#3838 Subgroup analysis of ORR and PFS of the SEQTOR study (GETNE 1206) – Everolimus followed by Streptozotocin (STZ)-5FU upon progression or the reverse sequence, in advanced progressive panNETs

Introduction: Previous global results of ORR and PFS1 have been presented. The best treatment (Tx) sequence between STZ-5FU and everolimus (EVE) in patients (pts) with advanced and progressive panNETs is not yet well established.

Conference:

Presenting Author: Salazar R

Authors: Capdevila J, Tafuto S, Krogh M, Teulé A, Garcia-Carbonero R,

Keywords: panNET, everolimus, STZ-5FU,

#3757 Subtype-specific landscape of splicing-associated neoantigens and mutations in pancreatic neuroendocrine tumors

Introduction: In pancreatic neuroendocrine tumors (PanNETs), there has recently been advancement in understanding the heterogeneity (metastases-like primary; MLP-1/2, intermediate, and insulinoma subtypes) and immunological landscapes. Immunotherapies provide modest therapeutic benefits to patients, which may be linked to low mutational neoantigen loads in PanNETs.

Conference:

Presenting Author: Sadanandam A

Authors: Sadanandam A, Lawlor R, Larkeryd A, Mahalingam A, Mafficini A,

Keywords: Pancreatic neuroendocrine tumor, isoform switching, subtype, mutation, neoantigens, splice variant, spliceosomal mutation, immunotherapy, immunosuppression,

#3379 Survey of neuroendocrine tumor patients’ experience of quality of care provided by a dedicated NET Dietitian

Introduction: The Birmingham Neuroendocrine Tumour (NET) service has a full time dedicated NET Dietitian for outpatient and inpatient care since August 2020.

Conference:

Presenting Author: Mair R

Authors: Mair R, Bradley E, Davis N, Shah T,

Keywords: net, DIETITIAN, QUALITY OF LIFE, SYMPTOM CONTROL,

#3217 Survey of challenges in access to diagnostics and treatment for neuroendocrine tumor (NET) patients (SCAN) - NET experts & NET healthcare

Introduction: SCAN assessed global delivery of healthcare to NET patients. This analysis provides a comparative perspective – Advanced Economies (AE) vs. Emerging and Developing Economies (EDE).

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: McDonnell M

Authors: McDonnell M, Kolarova T, Bouvier C, Pavel M, Singh H,

Keywords: access, NET specialist, NET healthcare, challenges, global,